CK Life Sciences

CK Life Sciences International (Holdings) Inc.
長江生命科技集團有限公司

Type	Listed company
Industry	Biotechnology
Founded	2000
Headquarters	Hong Kong
Area served	Hong Kong
Key people	Chairman: Mr. Victor Li
Parent	Cheung Kong Holdings
Website	CK Life Sciences International (Holdings) Inc.

CK Life Sciences International (Holdings) Inc. (Chinese: 長江生命科技集團有限公司) (SEHK: 775), or CK Life Sciences, is the subsidiary of Cheung Kong Holdings in Hong Kong. It is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products.^[1] The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings.

It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002 (Former stock code: SEHK: 8222).^[2][3] It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.^[4][5]

References

1. CK Life Sciences International Holdings Inc.
2. CK Life Sciences Bestowed Outstanding Biochemistry Technology Company Award by Capital Magazine
3. CK Life To Raise HK $2.93 Bn Via IPO
4. Li Ka-shing, Li Tzar-kuoi raise stake in CK Life Sciences
5. Transfer of Listing from GEM to Main Board

External links

• CK Life Sciences International (Holdings) Inc.